4//SEC Filing
Xenon Pharmaceuticals Inc. 4
Accession 0001171843-16-008526
$XENECIK 0001582313operating
Filed
Mar 10, 7:00 PM ET
Accepted
Mar 11, 5:19 PM ET
Size
5.4 KB
Accession
0001171843-16-008526
Insider Transaction Report
Form 4
GOLDBERG Y. PAUL
VP of Clinical Development
Transactions
- Award
Stock Option (Right to Buy)
2016-03-11+20,000→ 20,000 totalExercise: $7.49Exp: 2026-03-10→ Common Shares (20,000 underlying)
Footnotes (1)
- [F1]Vesting 25% on January 1, 2017, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.
Documents
Issuer
Xenon Pharmaceuticals Inc.
CIK 0001582313
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001582313
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 7:00 PM ET
- Accepted
- Mar 11, 5:19 PM ET
- Size
- 5.4 KB